KaloBios Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company develops monoclonal antibodies designed to improve the lives of seriously ill patients with difficult-to-treat diseases, focusing on respiratory diseases and cancer such as cystic fibrosis, asthma, pneumonia, and tumors. KaloBios serves patients throughout the United States.
442 Littlefield Avenue
South San Francisco, CA 94080